Analysis and design of protein interactions that regulate cell death

调节细胞死亡的蛋白质相互作用的分析和设计

基本信息

批准号：
10018034
负责人：
AMY E KEATING
金额：
$ 31.22万
依托单位：
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
依托单位国家：
美国
项目类别：
财政年份：
2014
资助国家：
美国
起止时间：
2014-06-01 至 2022-08-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/10018034
关键词：
Address Affect Affinity Apoptosis Apoptotic Area Autophagocytosis BAX gene BCL-2 Protein BCL2 gene Binding Binding Proteins Biological Biological Assay Biological Process Biology Cell Death Cell Death Signaling Process Cell Survival Cell surface Cells Cessation of life Code Complex Computer Models Computing Methodologies Diagnosis Disease Evolution Family Foundations Funding Grant Health Heart Diseases Human Immune response Ischemia Lead Libraries Life MCL1 gene Malignant Neoplasms Maps Mediating Membrane Methodology Methods Mitochondria Modeling Molecular Molecular Conformation Motivation Outcome Outer Mitochondrial Membrane Pathway interactions Peptides Pharmaceutical Preparations Play Process Protein Engineering Protein Family Proteins Proteome Reagent Regulation Research Role Route Signal Transduction Structural Models Structure Structure-Activity Relationship Technology Testing Therapeutic Therapeutic Intervention Time Variant Work alpha helix bak protein base biophysical analysis cancer therapy design experimental study human disease improved inhibitor/antagonist insight member mitochondrial membrane neoplastic cell nervous system disorder novel novel strategies pro-apoptotic protein protein function protein protein interaction prototype screening small molecule success therapeutic development therapy development tool working group

项目摘要

Protein-protein interactions control myriad biological processes important for human health. Tools for discovering, predicting and designing such interactions can provide insights into biological mechanisms and highlight possible routes to therapeutic intervention. This project will integrate computational and experimental approaches to advance our understanding of the relationships between sequence and function for protein interactions among Bcl-2 family proteins. The Bcl-2 family regulates apoptosis and autophagy by forming specific complexes, some of which inhibit and some of which promote cell death. Competition between pro- and anti-apoptotic Bcl-2 family proteins for binding to short alpha helices encoded by a Bcl-2 homology 3 (BH3) motif controls key cell survival decisions. It is now well established that peptides and small molecules can mimic or inhibit BH3 interactions. Such molecules provide a way to control signaling outcomes using exogenous reagents, as demonstrated by the first drug approved for treating cancer by targeting Bcl-2. Despite exciting progress, open questions about Bcl-2 protein interactions with BH3 motifs provide additional opportunities for discovery. In particular: Do as-yet undiscovered BH3 motif-containing proteins in the human proteome influence signaling through Bcl-2 family proteins? Why do some proteins that contain BH3 motifs trigger mitochondrial pore formation by pro-apoptotic BAK and BAX whereas others do not? What are the mechanisms of BH3 binding-induced conformational changes that lead to mitochondrial membrane pore formation and cell death? What opportunities exist for promoting or blocking such processes using designed peptides or proteins? Answers to these questions will impact analysis of Bcl-2 pathways important for multiple human diseases, provide new reagents, and guide development of therapies for cancer and other diseases. Building on the substantial successes that we realized in the previous funding period, we will drive progress in these areas by applying new methodology that integrates interaction screening with structural modeling and prediction. We will apply novel computational methods for predicting new Bcl-2 binding partners, test predictions of our models, and highlight candidate new interaction partners of biological significance. We will propose molecular mechanisms of BAK and BAX activation and test them using libraries of BH3 motif variants. We will apply new computational design methods to make peptides and mini-proteins that activate or inhibit BAK and BAX-mediated cell death. Collectively, our contributions will provide a map of the sequence-function landscape of BH3 motifs, which are critical factors controlling cell survival. The methods and tools developed in this work will also be useful for discovering and inhibiting other protein-protein interactions. !

蛋白质 - 蛋白质相互作用控制着对人类健康至关重要的许多生物学过程。工具发现，预测和设计这种相互作用可以提供对生物学机制的见解并强调了治疗干预的可能路线。该项目将整合计算和实验方法来促进我们对序列与序列之间关系的理解 Bcl-2家族蛋白之间蛋白质相互作用的功能。 Bcl-2家族调节凋亡和自噬通过形成特定的复合物，其中一些抑制，其中一些促进细胞死亡。亲凋亡和抗凋亡Bcl-2家族蛋白之间的竞争，以与短α螺旋结合由Bcl-2同源性3（BH3）基序编码控制关键细胞存活决策。现在已经建立了肽和小分子可以模仿或抑制BH3相互作用。这样的分子提供了一种方法使用外源试剂来控制信号传导结果，如批准的第一种药物所证明的通过靶向BCL-2治疗癌症。尽管进步令人兴奋，但关于BCL-2蛋白的问题与BH3图案的互动为发现提供了更多的机会。特别是：尚未做人类蛋白质组中未发现的BH3基序蛋白通过Bcl-2信号传导家庭蛋白质？为什么某些包含BH3基序的蛋白质会触发线粒体孔的形成亲凋亡的bak和bax而其他人没有？ BH3结合诱导的机制是什么导致线粒体膜孔形成和细胞死亡的构象变化？什么存在使用设计的肽或蛋白质促进或阻止此类过程的机会吗？这些问题的答案将影响对多个人类重要的BCL-2途径的分析疾病，提供新的试剂，并指导癌症和其他疾病疗法的开发。以我们在上一流期间意识到的巨大成功为基础，我们将开车通过应用将交互筛选与结构性整合的新方法，在这些领域的进展建模和预测。我们将应用新颖的计算方法来预测新的Bcl-2结合合作伙伴，对我们的模型的测试预测，并突出候选人的新互动伙伴意义。我们将提出Bak和Bax激活的分子机制，并使用 BH3主题变体的库。我们将应用新的计算设计方法来制造肽和激活或抑制BAK和BAX介导的细胞死亡的迷你蛋白质。总的来说，我们的贡献将提供BH3图案的序列功能景观的地图，这是控制的关键因素细胞存活。这项工作中开发的方法和工具也将用于发现和抑制其他蛋白质蛋白质相互作用。呢

项目成果

期刊论文数量（11）

专著数量（0）

科研奖励数量（0）

会议论文数量（0）

专利数量（0）

Potent and specific peptide inhibitors of human pro-survival protein Bcl-xL.

DOI：
10.1016/j.jmb.2014.09.030
发表时间：
2015-03-27
期刊：
JOURNAL OF MOLECULAR BIOLOGY
影响因子：
5.6
作者：
Dutta, Sanjib;Ryan, Jeremy;Chen, T. Scott;Kougentakis, Christos;Letai, Anthony;Keating, Amy E.
通讯作者：
Keating, Amy E.

Selective peptide inhibitors of antiapoptotic cellular and viral Bcl-2 proteins lead to cytochrome c release during latent Kaposi's sarcoma-associated herpesvirus infection.